Grandfield & Dodd, LLC Exact Sciences Corp Transaction History
Grandfield & Dodd, LLC
- $1.53 Billion
- Q1 2025
A detailed history of Grandfield & Dodd, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 112,760 shares of EXAS stock, worth $5.98 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
112,760
Previous 108,961
3.49%
Holding current value
$5.98 Million
Previous $6.12 Million
20.27%
% of portfolio
0.32%
Previous 0.4%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$946 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$935 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$663 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$640 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$351 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.38B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...